2011 Results: Most Admired Corporate Dealmaker awards, Deal Economy 2012
Subscriber Content Preview | Request a free trialSearch  
  Go

The Deal Economy 2012

Home    |    Event    |    Blog    |    Awards
Mission
-
Blog
-
Sectors
-
Archives

Last year's winners

Most Admired Corporate Dealmakers: 2011 Results

2011 Results

Our journalists did a deep dive into the winning companies' strategies. Click through and also see some videos our AV team shot on the road with the winners.


Long-distance runners

Most corporations that aim to increase revenue and market share at some point will make an acquisition. How many deals they do over time will depend on any number of factors, not least the scale of their ambition and their available opportunities.

History is littered with companies that have done lousy deals for all sorts of reasons -- overzealous empire building, overpaying, shoddy due diligence or getting caught when markets suddenly turn. The 2008 financial crisis famously caught just about everyone off guard. And while M&A resumed in earnest this year, many companies continue to divest assets and reconsider their strategic focus, particularly as the economy slows.

Many more continue to pile up cash, still spooked by memories of 2008 and concerns over the global economy. Besides, successful dealmaking is never easy. The Deal magazine's Most Admired Corporate Dealmakers survey, now in its fourth year, recognizes the difficulty, in good as well as tough times.

This year's winners are companies that have been selected by their peers -- lenders, lawyers, investment bankers, accountants and corporate executives -- who understand the challenges corporate dealmakers are up against and who are able to track who's doing the most consistently superior job.

In analyzing our surveys, we've found that successful corporate development teams tend to have strong convictions about strategies and how deals they target complement long-term goals. They have well-defined processes, are meticulous about due diligence and identify (and retain) key experts and talent.

These are some of the reasons we look at three years of deal history: A company's M&A strategy takes time to unfold or unravel. Share prices can rise and fall depending on the mood of the moment, and integration may take years to reveal synergies or cultural frictions.

Sometimes, too, the best dealmakers may be those who have the discipline to sit out the M&A dance and wait for the right partner to come along. All five of this year's MACD winners have, in their own ways, demonstrated such strengths. Take J.P. Morgan Chase & Co., which has won for a second consecutive year as best dealmaker in the financial sector. The bank has made no notable acquisitions since 2008, when it scooped up Bear Stearns Cos. and Washington Mutual Inc. Yet, its success has been based as much on risks avoided as on opportunities seized. Under chairman and CEO Jamie Dimon, the bank bailed out of subprime mortgages early, preserving its balance sheet when the crisis blew in and giving it the strength to pick and choose deals. In short, risk management is integral to a company's deal capabilities.

Then there's Oracle Corp., which paid $7.4 billion for Sun Microsystems Inc. That deal took it for the first time into hardware. Oracle was able to get investors on board because it has a record of doing deals that work. Exxon Mobil Corp. bought natural gas explorer XTO Energy Inc. for $41 billion when natural gas prices were in the dumpster. Exxon has looked prescient since.

As for Walt Disney Co., it continues to benefit from buying Marvel Entertainment Inc. for $4 billion in 2009. Disney has a reputation for knowing how to leverage deals through marketing and distribution; many continue to see this deal as a home run. Lastly, there's Abbott Laboratories, which is still absorbing Solvay Pharmaceuticals SA and Piramal Healthcare Ltd.'s healthcare solutions business -- acquisitions that gave it new market share in emerging markets, notably India. Abbott has been an MACD winner for four years running, suggesting the market believes its corporate development team knows what it's doing.

Survey recap

In March, working with Dealogic and Standard & Poor's Capital IQ unit, we published lists of the five most transaction-intensive large-cap companies in five industries: bio-pharma, information technology, energy, finance and consumer discretionary. To generate the lists, we looked at acquisitions and divestitures closed by the companies in the three years ended Dec. 31, 2010. Details and the lists are available online at www.thedeal.com/mostadmired/sectors.php.

We then invited readers to participate in an online survey, ranking the prowess of these companies in dealmaking and rating them on four criteria: strategy, execution, value and quality of the deal team. With 536 responses in when the survey closed in July, our survey firm, Rivel Research Group, tabulated the results and named the winners and runners-up in each sector. - Suzanne Miller